0001593968-24-000192.txt : 20240131 0001593968-24-000192.hdr.sgml : 20240131 20240131174237 ACCESSION NUMBER: 0001593968-24-000192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240125 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chang David D CENTRAL INDEX KEY: 0001611024 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 24584158 MAIL ADDRESS: STREET 1: C/O ALLOGENE THERAPEUTICS, INC. STREET 2: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 primary_01.xml PRIMARY DOCUMENT X0508 4 2024-01-25 0001737287 Allogene Therapeutics, Inc. ALLO 0001611024 Chang David D 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true true President and CEO false Common Stock 2024-01-25 4 A false 317800 0 A 4513203 D Common Stock 1201108 I See footnote Common Stock 856044 I See footnote Common Stock 856044 I See footnote Stock Option (Right to buy) 3.2 2024-01-25 4 A false 1123535 0 A 2034-01-25 Common Stock 1123535 1123535 D Includes 1492 shares of the Issuer's common stock acquired by the reporting person on September 15,2023 pursuant to an employee stock purchase program. Securities held in the name of the Chang 2006 Family Trust Securities held in the name of the JEC 2019 Trust dated October 1, 2019. Securities held in the name of the RTC 2019 Trust dated October 1, 2019. 1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter. /s/Earl Douglas, Attorney-in-Fact 2024-01-31